Snapshot

The Fast-track Registration pathway has been developed by the Ministry of Health and Prevention of the United Arab Emirates (MOHAP) of United Arab Emirates.

This pathway accelerates the regulatory review process.

It is an abridged review (a reliance pathway).

The Drug Registration Committee evaluates an application for a new drug within 15 working days of submission and makes the decision to approve or reject the application within 10 working days from the date of evaluation.